About the ANCA-Associated Vasculitis Working Group

The methods for creating a composite outcome are different than for individual domain-directed outcomes and this Workshop will help attendees understand the steps required for this process through a project that is funded by ACR and EULAR to create response criteria for ANCA-associated vasculitis for use in clinical trials. Attendees are encouraged before the Workshop to view the short but highly informative videos developed to inform everyone on the disease under study and the methods employed for this project.

Haner_Direskeneli

Haner Direskeneli

Co-Chair

sarah mackie

Sarah Mackie

Co-Chair

Peter Merkel

Peter Merkel

Co-Chair

gunnar

Gunnar Tómasson

Co-Chair

kaitlin quinn

Kaitlin Quinn

Fellow

Screen Shot 2021-02-17 at 11.40.13 AM

Sara Monti

Fellow

georgia lanier

Georgia Lanier

Patient Research Partner

Introduction to Antineutrophil cytoplasmic antibody ANCA-Associated Vasculitis

Introduction To Methodology To Develop A Composite Outcome Measure For ANCA-Associated Vasculitis

OMERACT Endorsed Core Domain Set for Clinical Trials in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

Screenshot 2024-01-30 at 12.23.58 PM

Working Group Members:

Alexa Meara
Beverley Shea
Carol Langford
Cristina Ponte
Georgia Lanier
Gulen Hatemi
Gunnar Tomasson
Haner Direskeneli
Kaitlin Quinn

Nataliya Milman
Peter Merkel
Peter Tugwell
Sara Monti
Sarah Mackie
Tanaz Kermani
Yesim Ozguler
Peter Grayson

Scroll to Top